Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
12 hedge funds and large institutions have $37.9M invested in Zealand Pharma A/S American Depositary Shares in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 8 closing their positions.
33% less funds holding
Funds holding: 18 → 12 (-6)
52% less capital invested
Capital invested by funds: $78.7M → $37.9M (-$40.7M)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$628K |
| 2 |
AIC
AWM Investment Company
New York
|
+$357K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$315K |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$248K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$19.2M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.19M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.02M |
| 4 |
RA
Royce & Associates
New York
|
-$785K |
| 5 |
Millennium Management
New York
|
-$600K |
ZEAL Hedge Fund Activity: Q4 2017 in Review
12 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q4 2017, worth a combined $37.9M — down 52% from $78.7M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ZEAL and 2 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 2 added.
The largest buyer was Fred Alger Management, opening a new position worth an estimated $628K. The largest seller was BVF Inc, exiting entirely with an estimated $19.2M sold.
- 12 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q4 2017, down from 18 in Q3 2017.
- Funds reported $37.9M of Zealand Pharma A/S American Depositary Shares stock for Q4 2017, down 52% quarter-over-quarter.
- 2 funds opened new Zealand Pharma A/S American Depositary Shares positions in Q4 2017 and 8 closed out, a net change of -6 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q4 2017 was Fred Alger Management, an estimated $628K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q4 2017 was BVF Inc, an estimated $19.2M sold.
Based on aggregated 13F filings for Q4 2017.